🌱 KidneyEnergy.com

← brief for 2026-10-08 · Slowing decline

Aldosterone synthase inhibitors: biological rationale, mechanism of action, and results of clinical trials.

Paper No results yet Peer reviewed

Key takeaways

This review explains how a new class of blood pressure drugs works. It looks at the science behind these medicines. The article summarizes existing trial results but does not present new data. It is a guide to understanding this new drug type.

Who did this work

Surma S · Narkiewicz K

Source

Paper · PubMed, Losartan and CKD, long-term use · 2026 Oct 1
https://pubmed.ncbi.nlm.nih.gov/42847230/